Scarica l'app Stockscreener
6.53
0.77%
0.05
Kezar Life Sciences Inc Azioni (KZR) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-09-30 | 2025-07-01 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
11.71
|
- | 17.63 | 21.56 | 21.95 |
| Operating Income/Loss |
-11.71
|
- | -17.63 | -21.56 | -21.95 |
| Income/Loss From Continuing Operations Before Tax |
18.08%
-11.23
|
-13.70 | -16.56 | -20.22 | -20.31 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
18.08%
-11.23
|
-13.70 | -16.56 | -20.22 | -20.31 |
|
Net Income/Loss
|
18.08%
-11.23
|
-13.70 | -16.56 | -20.22 | -20.31 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
7.3231
|
- | 7.3057 | 0.00328 | 7.2962 |
| Diluted Average Shares |
7.3231
|
- | 7.3057 | 0.00328 | 7.2962 |
| Basic Earnings Per Share |
-1.53
|
- | -2.27 | -2.77 | -2.78 |
| Diluted Earnings Per Share |
-1.53
|
- | -2.27 | -2.77 | -2.78 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.99%
3.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):